Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
about
A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptakeIndium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer.Review article: current status of gastrointestinal carcinoids.Somatostatin analogs and radiopeptides in cancer therapy.Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.The expanding role of somatostatin analogs in the management of neuroendocrine tumors.Somatostatinoma: clinico-pathological features of three cases and literature reviewed.Somatostatin receptor scintigraphy in thoracic diseases.Dual tracer functional characterization of metastatic gastric carcinoid.Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Profiling of ileal carcinoids.Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors.ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours.Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour.Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience.Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I
P2860
Q28346172-A5C0DD5B-2E7E-494A-B91A-338B723E0E5DQ31104663-AA3839D7-8CBA-4F73-ACF9-2472DF6695E3Q33548211-5FD31702-DC48-46D0-9547-CD9E001B9D19Q34972896-420C5DBC-630F-4610-B6A5-5241F34A7536Q35371197-474ED97E-C0E3-44FB-9514-BA557599DE5CQ36008285-A4BA3C89-320D-48DD-8099-EF6CD70FCFD0Q36047418-65823580-8AA3-4899-86F0-60F79161F0F8Q36347272-2792B805-E570-498F-92D2-63C73DED051BQ36889060-8AFAA6CB-2B64-4675-982F-51A880887298Q37030460-7E50F74A-F395-4B98-B7AB-250FA10CD028Q37150867-39DDC293-57B7-41B5-9EBD-F9B2441025C2Q37634917-B1E3CEAA-485D-458C-A04E-744DB150B21BQ38044219-2FCBFDF7-015C-4C5B-AED0-D0C790D3B431Q38782137-3BC7D379-287B-4D7F-BC75-660F20FCB5E8Q42182547-61265D66-27F4-4C12-8299-D447639ABDD6Q43200565-59829F91-C96C-4956-9DA0-F5B3D4C9A706Q44299626-2E1E4B4B-23B2-4A5C-96C6-C3078B73758BQ46938257-57878E7F-7F95-4FE0-8012-8EF34AEE7C15Q54473967-70D9D251-27BE-44C7-80BA-EDA6FEAE55ADQ59304712-41BC674F-49AA-47E1-A9EA-0FBBE74B1F59
P2860
Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Comparative studies on the exp ...... tients with carcinoid tumours.
@ast
Comparative studies on the exp ...... tients with carcinoid tumours.
@en
type
label
Comparative studies on the exp ...... tients with carcinoid tumours.
@ast
Comparative studies on the exp ...... tients with carcinoid tumours.
@en
prefLabel
Comparative studies on the exp ...... tients with carcinoid tumours.
@ast
Comparative studies on the exp ...... tients with carcinoid tumours.
@en
P2093
P2860
P356
P1476
Comparative studies on the exp ...... tients with carcinoid tumours.
@en
P2093
Fjälling M
Forssell-Aronsson E
Wigander A
William-Olsson L
Wängberg B
P2860
P2888
P304
P356
10.1038/BJC.1998.101
P407
P577
1998-02-01T00:00:00Z
P5875
P6179
1056443420